S 4238 New Jersey Senate · 2026-2027 Regular Session

Establishes "End-Stage Kidney Disease Prevention and Innovation Act"; appropriates $10 million.

This bill creates the "End-Stage Kidney Disease Prevention and Innovation Act" to establish research centers focused on rare kidney diseases within New Jersey's Department of Health. It allocates $10 million to fund grants and cooperative agreements with public and private nonprofit organizations, prioritizing those that serve underserved and minority communities. The funding supports activities such as conducting medical research, training healthcare providers, developing public awareness materials, and offering fellowships to specialists in nephrology. Additionally, the legislation mandates a study on diagnostic methods and treatment options while ensuring that research evaluations do not discriminate against individuals with disabilities.
Bill status in committee 1 of 4 stages cleared
Introduction
May 2026
Committee Review
Floor Vote
Governor
Introduced May 14, 2026 Last action May 14, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
1
Key actions
0
Committee
0
May 14, 2026
Introduced
Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
upper
1 primary · 0 co-sponsors

Sponsors

Role
Legislator
Party
State
District
P
Photo of Benjie Wimberly
Benjie Wimberly
DDemocratic
NJ
35